I now have enough information to provide a thorough, well-sourced answer. Here it is:
Causes of Bilateral Ankle + Finger/Wrist Joint Pain in a Patient with Hansen's Disease on MDT (1 Month)
This presentation has three main plausible causes, and they can overlap. Given the timing (1 month into multidrug therapy / MDT), lepra reactions triggered by treatment are the most likely explanation.
1. Type 2 Reaction - Erythema Nodosum Leprosum (ENL) [Most Likely]
ENL is a Type III hypersensitivity (immune complex) reaction seen in multibacillary patients (BL and LL types). It is classically triggered or worsened by starting MDT, particularly rifampicin, because the rapid bacterial kill releases large amounts of antigen into the circulation.
Key features:
- Fever, malaise, and systemic upset
- New tender subcutaneous nodules appearing in crops on limbs and face
- Joint pain is a recognized feature - fever + joint pain + red eyes listed as classic ENL associations (Park's Preventive Medicine)
- The bilateral, symmetrical pattern of ankle involvement fits ENL's symmetrical distribution
- Small joint involvement (fingers, wrist) is also seen
According to Bradley & Daroff's Neurology: "In ENL...inflammation of muscles, joints, testes, and eyes may also develop."
The timing - 1 month after starting MDT - is a classic window for ENL onset.
2. Type 1 Reaction - Reversal Reaction (RR) [Possible, especially if borderline leprosy]
RR is a Type IV delayed hypersensitivity reaction occurring in unstable borderline cases (BT, BB, BL). It occurs when MDT shifts immunity toward the tuberculoid end of the spectrum, upregulating TNF-alpha, IFN-gamma, and IL-2.
Key features related to joints:
- Predominantly causes neuritis - painful, enlarged nerve trunks
- The periarticular neuritis (ulnar nerve at wrist/elbow, median nerve, peroneal nerve at ankle) produces pain that can mimic or co-exist with true joint pain
- Wrist and finger pain may reflect ulnar or median nerve trunk neuritis rather than true arthritis
- Ankle pain may reflect common peroneal or posterior tibial nerve trunk involvement
From Harrison's (22E, 2025): "The reversal reaction can occur at any time during treatment...resulting in exacerbation of rash and neuropathy as well as appearance of new lesions."
3. Neuropathic (Charcot) Arthropathy
In established leprosy with sensory neuropathy, loss of protective sensation leads to chronic repetitive microtrauma and Charcot joint disease, particularly affecting:
- Ankles and feet (most common lower limb site)
- Small joints of the hands
From Campbell's Operative Orthopaedics (2026): Leprosy is listed as a recognized cause of neuropathic arthropathy. From Miller's Review of Orthopaedics: "Leprosy (Hansen disease) - second most common cause in upper extremity" for Charcot arthropathy.
However, true Charcot joints typically develop after longer duration of untreated neuropathy - less likely at only 1 month post-diagnosis but possible if neuropathy was pre-existing.
4. Direct Synovial Infiltration by M. leprae (Leprous Arthritis)
Less common but documented - M. leprae can directly infiltrate synovium, causing:
- Chronic, indolent monoarthritis or oligoarthritis
- Migratory polyarthritis resembling rheumatoid arthritis
- As noted in the 2025 Best Practice & Research Clinical Rheumatology review (PMID 39915143): "Chronic arthritis [in leprosy] may present diagnostic challenges due to its resemblance to other inflammatory arthritides."
Summary Table
| Cause | Mechanism | Pattern | Timing |
|---|
| ENL (Type 2 reaction) | Immune complex (Type III) | Bilateral, symmetrical, large + small joints, systemic | Triggered by MDT start |
| Reversal reaction (Type 1) | Delayed hypersensitivity (Type IV) | Periarticular neuritis mimicking arthritis; borderline cases | During MDT, any time |
| Neuropathic (Charcot) arthropathy | Loss of protective sensation - microtrauma | Ankles, foot joints, hand joints | Pre-existing neuropathy |
| Direct M. leprae synovitis | Bacterial infiltration of synovium | Oligo/polyarthritis | Any time |
Clinical Priority
ENL is the most urgent diagnosis to consider in this patient given:
- Only 1 month into MDT (rifampicin-induced antigen release is a classic trigger)
- Bilateral symmetric ankle joint involvement (characteristic of ENL)
- Small joint involvement of both hands
Management implications: severe ENL requires prednisolone (or thalidomide in refractory cases). Rifampicin is sometimes withheld during active ENL reactions. Continue clofazimine, which itself has some anti-ENL activity (though slow-onset over 4-6 weeks).
Sources: Harrison's Principles of Internal Medicine 22E (2025), Park's Textbook of Preventive & Social Medicine, Bradley & Daroff's Neurology in Clinical Practice, Campbell's Operative Orthopaedics 15E (2026), Fitzpatrick's Dermatology; Cruz et al., [Best Pract Res Clin Rheumatol 2025 (PMID 39915143)]